• Webull Australia has removed commission on US, Hong Kong, and China A-Share trading.
• The move follows Webull’s existing $0 commission on US and Australian ETFs, completing its transition to zero-commission trading across key asset classes.
• Webull Australia is now the only major Australian platform offering $0 commission across US, Hong Kong, and China A-Share markets from a single app – and one of the lowest-cost platforms in Australia.
• Webull Australia has won the WeMoney 2026 Award for Best Low-Cost Broker.

SYDNEY, April 2, 2026 /PRNewswire/ — Webull Securities (Australia) Pty Ltd (“Webull Australia”), a subsidiary of Webull Corporation (NASDAQ: BULL), the owner of the Webull trading platform, today announced the removal of trading commission fees on US, Hong Kong, and China A-Share trades.

The change positions Webull as one of Australia’s lowest-brokerage-cost platforms for international share trading.

“We’ve set a new benchmark for trading fees in Australia,” said Rob Talevski, CEO of Webull Australia. “This is a fundamental change to how we price trades on the platform, made possible by the scale and global infrastructure of our Nasdaq-listed parent company.”

Commission-free trading has become prevalent in markets where tech-first brokers dominate market share. In Australia, that shift has been slower, as cash constraints among neo-brokers and legacy earnings models, tied to traditional brokers, have led to platform dependencies on higher fees.

Webull’s business model relies on scale and geographical expansion rather than high fees, and this is why it has been able to extend $0 pricing across the US, Hong Kong, and China A-Share markets simultaneously – all accessible from a single platform.

“The client journey used to be about picking a market they want to trade, then finding the platform that supports it. Now investors don’t have to make that trade-off,” Talevski added. “ASX and US ETFs, US equities, Hong Kong-listed stocks, China A-Shares – they’re all on the Webull platform, and they’re all now zero commission. We’re bringing the US trading culture of ‘zero commission trading’ to Australia. And we’re the first ones to do it so extensively.”

Webull’s international brokerage schedule changes are as follows:

• US Share Trading: previously 0.025% × trade value (minimum $1.00), all trading hours — now $0.
• Hong Kong Share Trading: previously $0.0003 × trade value (minimum $15) — now $0.
• China A-Shares: previously $0.0003 × trade value (minimum $15) — now $0. 

US and Australian ETFs, which Webull had already reduced to zero brokerage, will remain priced as such.

Webull’s platform provides access to CHESS-sponsored Australian equities and ETFs, US ETFs and equities, Hong Kong equities, China A-Shares, advanced US options, and cryptocurrencies. US markets are accessible 24 hours a day, five days a week.

Webull Australia is the WeMoney 2026 Award Winner for Best Low-Cost Broker.

Webull Australia is available via the Webull app. Users can open an account at www.webull.com.au.

###

About Webull Australia

Webull Securities (Australia) Pty. Ltd. is a leading financial services provider, holding an Australian Financial Services Licence (AFSL 536980) and regulated by the Australian Securities and Investments Commission (ASIC). As a trading participant of both the Australian Securities Exchange (ASX) and Cboe Australia (Cboe), and a principal member of the Stockbrokers and Investment Advisers Association, Webull strives to ensure the highest standards of service and security. Learn more at webull.com.au.

About Webull

Webull Corporation (NASDAQ: BULL) owns and operates Webull, a leading digital investment platform built on next-generation global infrastructure. Through its global network of licensed brokerages, Webull offers investment services in 14 markets across North America, Asia Pacific, Europe, and Latin America. Webull serves more than 26 million registered users globally, providing retail investors with 24/7 access to global financial markets. Users can put investment strategies to work by trading global stocks, ETFs, options, futures, fractional shares, and digital assets through Webull’s trading platform, which seamlessly integrates market data and information, its user community, and investor education resources. Learn more at webullcorp.com.

Media Enquiries

Cognito for Webull: webull@cognitomedia.com.

PUNE, India, April 2, 2026 /PRNewswire/ — EKA Mobility, a leading electric vehicles and technology company, today announced a strong 5X year-on-year volume growth in FY 2025–26, with 1,143 units sold and 1,344 electric commercial vehicles produced. This milestone comes on the back of the company’s comprehensive electric vehicle portfolio across segments. During the year, EKA entered the M&HCV truck segment, in addition to its existing bus and SCV portfolio. The company is a Champion OEM under the Auto PLI Scheme and has achieved certification across multiple platforms.

EKA Mobility’s Range of Electric Commercial Vehicles (eBuses, eTrucks & eSCVs)

“FY 2025–26 is a defining year for EKA Mobility. We are not only scaling volumes but also expanding our manufacturing footprint by adding a new plant recently and increasing our planned annual capacity to 10,000 buses, 6,000 trucks and 24,000 SCVs. With the widest range of fully homologated, born-electric platforms from last-mile to long-haul, we are uniquely positioned as a full-stack EV company. Our growth across electric buses, small commercial vehicles, and now trucks validates both market demand and our execution capability.

India’s transition to clean commercial mobility is accelerating, and EKA is at the forefront driving this shift at scale, with technology, innovation, and global ambition.”

— Dr. Sudhir Mehta, Founder & Chairman, EKA Mobility

Strong Business Momentum Across Segments

• Electric Bus Leadership:
  Secured wins under PM e-Bus Sewa and PM E-DRIVE; deployed vehicles across 15+ states including Maharashtra, Gujarat, Uttar Pradesh, Karnataka, and Delhi
• SCV Breakout Year:
  Strong uptake of 3S & 6S passenger vehicles and 3W cargo platforms, accelerating last-mile mobility adoption
• Electric Trucks:
  New Growth Engine: Entry into heavy-duty trucks contributing to growth and expanding presence in logistics electrification
• Hydrogen Fuel Cell:
  Deployed a 9-metre hydrogen fuel cell bus at Cochin International Airport with KPIT Technologies and BPCL; plans to deploy 15 more buses

Key Highlights:

Global Expansion:

• Commenced electric bus deployments in Africa
• Partnership with Kerchanshe Group for CKD assembly and distribution
• Agreement with NBFI Capital for manufacturing in Australia

Manufacturing Scale-Up:

• Two Pune facilities operational; Pithampur plant to be operational shortly
• Planned annual capacity: 10,000 buses, 6,000 trucks and 24,000 SCVs

Retail Network:

• Expanded dealership network; plans to add 120 dealerships in FY27

Order Book Visibility:

• 6,000+ confirmed e-buses to be delivered over the next two years

About EKA Mobility

EKA Mobility is a Pune-based electric vehicle and technology company focused on transforming India’s commercial mobility landscape. With a portfolio spanning electric buses, electric trucks, and small commercial vehicles, EKA combines electric vehicle manufacturing with proprietary AI-powered fleet technology to deliver end-to-end mobility solutions.

EKA Mobility is backed by Mitsui & Co., Ltd. (Japan), VDL Groep (Netherlands), Pinnacle Industries Limited, Enam Holdings and the NIIF India-Japan Fund as equity and strategic partners and has expanded its footprint to markets in East Africa, South Africa, and Australia.

To know more about the company, kindly visit: https://ekamobility.com 

ALPHARETTA, Ga., April 2, 2026 /PRNewswire/ — Arclin, a global materials science company, today announced that it has completed the acquisition of DuPont’s Aramids business, including the renowned Kevlar® and Nomex® brands, for approximately $1.8 billion. The transaction marks a transformational milestone for Arclin, significantly expanding its scale, capabilities, and presence across life-critical industries. Arclin is a portfolio company of an affiliate of TJC, L.P.

Acquisition Fast Facts

“Kevlar® and Nomex® are the gold standard in their respective industries, and we are very excited to incorporate the Aramids platform into Arclin’s broader material science portfolio. This acquisition strategically strengthens Arclin’s operational and geographic footprint,” said Mark Glaspey, Arclin’s President. “With established manufacturing operations in Europe and Asia and ~1,800 new team members around the world, we are focused on operational continuity from day one while investing in manufacturing capabilities and innovation to support long-term growth.”

With the addition of the Aramids brands, Arclin’s portfolio now spans aerospace, electrical infrastructure, electric vehicles, and personal protection and defense. The acquisition further strengthens Arclin’s leadership across construction, infrastructure, transportation, and weather and fire protection as demand for advanced protective materials continues to grow. Arclin’s proprietary materials and technologies are mission-critical, supporting products that protect people, communities, and essential infrastructure worldwide.

“We’re excited to join the Arclin family and continue advancing the renowned performance that customers have relied on from Kevlar® and Nomex® for decades,” said Matt Reinhardt, Business Unit President for Aramids. “Our team’s deep expertise in aramid fiber technology, combined with Arclin’s commitment to investing in innovation and growth, positions us to better serve our customers and accelerate the development of next-generation protective solutions across industries.”

“Looking ahead, our mission is to build on the superior strength of the Aramids brands,” said Bradley Bolduc, Arclin’s Chief Executive Officer. “We’re focused on accelerating what these materials can do, putting meaningful investment behind technological innovation and deploying Kevlar® and Nomex® strategically across the world’s most performance-critical applications.”

Piper Sandler & Company served as financial advisor and Kirkland & Ellis LLP served as legal counsel to Arclin and TJC. Centerview Partners and Goldman Sachs & Co. LLC served as DuPont’s financial advisors and Skadden, Arps, Slate, Meagher & Flom LLP served as legal counsel.

About Arclin
Arclin is a leading materials science company and manufacturer of polymer technologies, engineered products, and specialized materials for the construction, agriculture, transportation infrastructure, weather & fire protection, pharmaceutical, nutrition, electronics, design, and other industries. Headquartered in Alpharetta, Georgia, Arclin has offices and manufacturing facilities across North & South America, Europe, and Asia and serves customers worldwide. For more information, visit www.arclin.com.

About TJC
TJC, L.P., formerly known as The Jordan Company, has worked for more than 40 years with CEOs, founders and entrepreneurs across a range of industries including Consumer, Diversified Industrials, Healthcare, Industrial Technology, Logistics & Business Services and Digital & Power Infrastructure. With $30.9 billion of assets under management as of September 30, 2025, TJC is managed by a senior leadership team that has invested together for over 24 years on over 90 investments. TJC has offices in New York, Chicago, Miami and Stamford. For more information, please visit www.tjclp.com.

About DuPont
DuPont (NYSE: DD) is a global innovation leader, providing advanced solutions that help transform industries and improve everyday life across our key markets of healthcare, water, construction, and industrial. More information about the company, its businesses and solutions can be found at www.dupont.com. Investors can access information included on the Investor Relations section of the website at investors.dupont.com.

Arclin Media Contact
Jana Wright
Chief Marketing & Communications Officer
inquiries@arclin.com 

Kevlar® and Nomex® are registered trademarks of Arclin. DuPont™ is a trademark of affiliates of DuPont de Nemours, Inc.

Over 100 Zeus liner and heat shrink components will now be available to engineers through Chamfr’s online marketplace to accelerate medical device development.

ORANGEBURG, S.C., April 2, 2026 /PRNewswire/ — Zeus, a global leader in advanced polymer solutions and catheter manufacturing, announced a partnership with Chamfr to make more than 100 liner and heat shrink products readily available through Chamfr’s online marketplace. The collaboration gives device engineers faster, on-demand access to critical components used in catheter development and prototyping.

“We understand that speed-to-market can make all the difference in the success of an end device,” said Jim O’Connell, Chief Commercial Officer at Zeus. “By making Zeus components available through Chamfr, we’re giving engineers easier access to the materials they need to prototype, test, and advance their designs.”

Chamfr is the leading digital marketplace for medical device components, equipment, tools, and service providers, connecting manufacturers with engineers searching for high-performance materials to solve complex design challenges and speed up product development. By bringing Zeus products to the platform, engineers can more quickly discover, evaluate, and source the materials needed to develop next-generation medical technologies.

“Chamfr has built a powerful platform that connects engineers with the components they need to innovate faster – all in one place,” said Mike Evers, Director of Commercial Marketing at Zeus. “By partnering with Chamfr, we’re expanding access to the high-performance materials engineers rely on during early-stage development.”

Products available through the marketplace include FEP heat shrink, FluoroPEELZ™ peelable heat shrink, PTFE Sub-Lite-Wall™ liners, and PTFE StreamLiner™ catheter liners, with additional Zeus products expected to be added over time.

QUICK FACTS

• Zeus is partnering with Chamfr to add 100+ liner and heat shrink products to Chamfr’s online marketplace.
• The new partnership is designed to help medical device engineers expedite the prototyping and development of next-generation medical technologies.
• Zeus products added to the platform include a range of PTFE liners, FEP heat shrink, and FluoroPEELZ™ peelable heat shrink products.

For more information, visit: www.zeusinc.com/Chamfr

ABOUT ZEUS

Zeus, headquartered in Orangeburg, South Carolina, is the world’s leading polymer extrusion and catheter design manufacturer. More than 60 years of experience in medical, aerospace, energy, automotive, fiber optics, and more allows Zeus to achieve its mission to provide solutions, enable innovation, and enhance lives. The company employs over 2,200 people worldwide with facilities in Aiken, Columbia, Gaston, Orangeburg, St. Matthews, South Carolina; Branchburg, New Jersey; Chattanooga, Tennessee; San Jose, California; Arden Hills, Minnesota; Guangzhou, China; and Letterkenny, Ireland.

For more information, visit www.zeusinc.com

Pressing issues in oncology, including rising cancer incidences in younger people, plus global opportunities for improving outcomes, were presented alongside cutting-edge research and clinical guidelines updates, during yearly event hosted by the National Comprehensive Cancer Network.

ORLANDO, Fla., April 2, 2026 /PRNewswire/ — The National Comprehensive Cancer Network^® (NCCN^®)—a non-profit alliance of leading cancer centers—brought together more than a thousand oncology professionals at the NCCN 2026 Annual Conference in Orlando, Florida, with hundreds more joining virtually. This year’s event featured educational sessions on the latest breakthroughs in cancer prevention and treatment, clinical guidelines updates, guidance for improving cancer center operations, plus panel discussions on critical issues in care delivery.

The NCCN 2026 Annual Conference opened with a plenary session exploring the causes of an alarming rise in cancer incidence in people under 50, and how providers should adjust to this new reality. Learn more at NCCN.org/conference.

“We gain so much from gathering together to share ideas and best practices, make new connections, and forge new collaborations,” said Crystal S. Denlinger, MD, CEO, NCCN. “Conference attendees tell us they feel a renewed energy and hope for the future after discussing how cancer care has advanced over the past year. This helps us all serve our patients better and ensure they experience the best care and outcomes possible.”

The New Face of Cancer: Supporting Younger Adults Across the Care Continuum

The conference opened with a plenary session exploring the causes of an alarming rise in cancer incidence in people under 50, and how providers should adjust to this new reality. The panel members agreed that there are likely several contributing factors, including diet and lifestyle, microbiome, and environmental hazards.

Speakers noted that scheduling and financial toxicity are particularly troublesome for younger people who are at a different stage in their life and career when they embark on their cancer journey. Some may have complicated commitments due to young children while others may not be thinking about building a family yet or be aware of how treatment may impact fertility. Their experiences going through therapy can be isolating from both their peers—who are living very different lives—and their fellow patients, who are typically older.

The hope is that these patients go on to live for many years, making it particularly important to take long-term side effects from treatment into account. At the same time, adolescents and young adults are often diagnosed at a later stage due to being below the age threshold for screening, rarity making symptoms less likely to be identified, plus an increased likelihood of a genetic component. According to the panel, more education is needed within the healthcare community and beyond, to better prepare survivors and health care systems to achieve optimal results.

“All patients, but particularly early-onset adults, should have a full team providing multidisciplinary, holistic care,” said panel moderator Christopher Lieu, MD, University of Colorado Anschutz Cancer Center, Vice-Chair of the NCCN Board of Directors. “Adolescents and young adults with cancer have unique challenges and rely on supportive services to ensure good quality of life through treatment and for years to come.”

The speakers noted that the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines^®) for Adolescents and Young Adults (AYA) are a helpful resource on this topic.

Delivering Cancer Care Worldwide: Current Realities and Future Strategies

A second plenary session tackled cancer care around the world, with a focus on the growing burden and new opportunities to address it. The panel pointed out that cancer rates are rising dramatically and disproportionately, with the vast majority of deaths occurring in low- and middle-income countries (LMICs). However, only 5% of the world’s cancer funding is spent on these regions.

Speakers highlighted that there are numerous opportunities to make a significant difference with a big return on investment. Those include standardizing treatments worldwide while upscaling prevention—such as HPV-vaccination uptake and access to screening. But there are new challenges from funding cuts that undermine progress, plus siloed efforts that seek to reinvent the wheel. Staffing limitations and regional disparities in resources contribute to the burden.

“Well-conceived programs can make an incredible difference in these settings,” said panelist Anu K. Agrawal, MD, Vice President, Global Cancer Support, American Cancer Society (ACS). “A lot of people are very interested in helping; we just need them to work together. We must move swiftly to action and support cancer-related policies with practical resources.”

Speakers celebrated the collaboration between the African Cancer Coalition, ACS, and NCCN for creating and maintaining the International Adaptations of the NCCN Guidelines^® for Sub-Saharan Africa as one example of a program that is finding success. The panel also showcased the NCCN Guidelines Middle East and North Africa (MENA) Editions, a collaborative effort with the Ministry of National Guard—Health Affairs (Saudi Arabia). Learn more about these, and other initiatives, at NCCN.org/global.

Operational Excellence in Cancer Care

New this year for in-person attendees, NCCN offered an educational track on best practices for oncology program operations. It included sessions on the role of guidelines in addressing systemic and practical challenges to care, optimizing academic/community collaborations, artificial intelligence (AI) innovation and governance, and policy insights.

“The NCCN Guidelines were downloaded more than 18 million times last year. That is a sign that people want to do the right thing and provide the best care that they can,” said Lawrence N. Shulman, MD, MACP, FASCO, Abramson Cancer Center at the University of Pennsylvania, Member of the NCCN Best Practices Committee and Policy Advisory Group. “New advances have benefited our patients, who are living longer, which is great news. But they stay in our practices longer, and together with the growing number of new cancer patients in the U.S., our oncology work force is ever more strained. We need to make care more efficient with improved electronic health records (EHRs), other technologies, and reducing administrative burdens.”

New Research and More

The conference featured more than 300 original research abstracts, covering topics such as:

• Best Practices
• Bioinformatics/IT
• Case Studies
• Clinical Oncology
• Correlative/Genomic
• Epidemiology/Risks/Prevention
• Outcomes
• Pre-Clinical Oncology
• Quality Improvement
• Trials in Progress

In-person attendees had an opportunity to embark on expert-guided tours through both days of posters. Top abstracts on topics like “Integrating Print-to-Web Outreach into Mammography Workflows to Promote Lung Cancer Screening: A Feasibility Study,” “A Phase I Study of Safety and Immunogenicity of Survivin Long Peptide Vaccine (SurVaxM) in Patients with Metastatic Neuroendocrine Tumors (NETs),” and “Increasing Equitable Adherence to Annual Lung Cancer Screening and Diagnostic Surveillance: A Pragmatic Factorial Trial” were presented as talks during a live session. Past NCCN Foundation^® Young Investigator Award winners presented talks on topics including: “Evolving Toward Precision Oncology in Osteosarcoma” and “Characterizing the Peripheral T-cell Repertoire in Patients with Unresectable Melanoma Treated with IO102-IO103 and Nivolumab-relatlimab.”

The posters included an abstract from Taneal D. Carter, DHSc, MPA, MS, Senior Manager of the NCCN Cancer Care Equity Program, et. al., on a pilot project utilizing the Health Equity Report Card to assess and promote equitable practices in community care settings, through funding from the Alliance for Equity in Cancer Care.

Conference participants learned about clinical guideline updates for gastrointestinal, genitourinary, gynecologic, hematologic, and skin cancers, as well as case study discussions for breast and non-small cell lung cancers. Sessions also featured information on managing immune checkpoint inhibitor toxicities, clinical applications and emerging trends in AI technology, and other topics.

Next year, the NCCN Annual Conference moves to San Diego, California for the first time. Save the dates: Friday, March 19 – Sunday, March 21, 2027. Visit NCCN.org/conference to learn more.

About the National Comprehensive Cancer Network
The National Comprehensive Cancer Network^® (NCCN^®) is a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education. NCCN is dedicated to defining and advancing quality, effective, equitable, and accessible cancer care and prevention so all people can live better lives. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines^®) provide transparent, evidence-based, expert consensus-driven recommendations for cancer treatment, prevention, and supportive services; they are the recognized standard for clinical direction and policy in cancer management and the most thorough and frequently-updated clinical practice guidelines available in any area of medicine. The NCCN Guidelines for Patients^® provide expert cancer treatment information to inform and empower patients and caregivers, through support from the NCCN Foundation^®. NCCN also advances continuing education, global initiatives, policy, and research collaboration and publication in oncology. Visit NCCN.org for more information.

Media Contact:
Rachel Darwin
267-622-6624
darwin@nccn.org

The NCCN 2026 Annual Conference featured more than 300 original research abstracts, Learn more at NCCN.org/conference.

HONG KONG, April 2, 2026 /PRNewswire/ — The Young Financial Planners Association (YFPA) successfully held its inaugural “YFPA Financial Education Forum – Money Monkey FinEd Forum” on 28 March 2026 at CyberArena, Cyberport. The Forum marked one of the Association’s flagship annual financial education initiatives and was organised in support of the territory-wide “Hong Kong Money Month” campaign led by the Investor and Financial Education Council (IFEC).

Through professional dialogue and interactive exchange, the Forum aimed to enhance public financial knowledge and promote sound financial values across different sectors of society.

The event attracted over 170 students, educators, invited guests and members of the public. The atmosphere was vibrant and highly engaging. The Forum was also broadcast live on social media platforms, enabling wider community participation. Recorded content will be developed into educational materials to further extend the social impact of financial literacy promotion.

Distinguished Host and Esteemed Panelists

In-Depth Dialogue on Five Key Financial Themes

The Forum was hosted and moderated by renowned Hong Kong media personality Mr. Stephen Chan Chi Wan, who led a dynamic roundtable discussion with four distinguished guest speakers from academia and the financial sector:

• Prof. Christina YU Wai Mui
• Mr. Francis KWOK Sze-Chi
• Prof. Amy YEUNG
• Prof. Simon LEE Siu Po

Representing expertise across academic research, market practice, economic analysis and youth education, the panel offered forward-looking insights and practical advice from multiple perspectives.

The discussion focused on five core themes:

• Savings planning and fundamentals of financial management
• Personal investment strategies and risk management
• Women’s financial management and evolving consumption patterns
• Macroeconomic trends analysis
• Greater Bay Area development opportunities and youth positioning

By integrating professional theory with real-world experience, the speakers unpacked complex economic topics in an accessible and engaging manner, helping participants build a structured and practical financial mindset. The Q&A session saw enthusiastic participation from students and attendees, reflecting the Forum’s high level of engagement and interactivity.

Strong Support from the Education Sector

Youth Experience the Power of Financial Knowledge Firsthand

The Forum received strong support from various schools, including Yan Chai Hospital Tung Chi Ying Memorial Secondary School and TWGHs Kwok Yat Wai College, which organised teachers and students to attend. Students were highly attentive throughout the sessions and actively participated in discussions, demonstrating strong interest in financial planning and economic issues.

The venue adopted an interactive stage format, moving beyond the traditional one-way seminar model. This setup fostered an open, relaxed and inspiring exchange environment, making financial education more relatable to young people and their daily lives.

Founder’s Vision

Building Financial Literacy as a Foundation for Youth Development

Mr. Kingsley Yee, Chairman and Founder of YFPA, shared the Association’s founding vision and development journey during the Forum. He emphasised that financial education goes beyond money management—it is a fundamental life skill that cultivates responsibility, planning ability and long-term vision.

“Young people who establish sound financial values and habits early in life will enhance their personal competitiveness and contribute to overall economic stability and sustainable development in society,” he said.

YFPA will continue to promote financial literacy through diversified programmes and cross-sector collaborations, benefiting more young people and families in the years ahead.

Continuing to Advance Financial Literacy in Society

Founded in 2022, YFPA is a charitable institution exempt from tax under Section 88 of the Inland Revenue Ordinance. The Association is dedicated to enhancing youth financial literacy as its core mission. In recognition of its contributions and achievements in youth financial education, YFPA was honoured with the “Investor and Financial Education Award” by the IFEC in 2024 and 2025.

The successful launch of the inaugural Financial Education Forum marks a significant milestone in YFPA’s journey to promote financial literacy. Moving forward, YFPA will continue responding to societal needs by advancing financial knowledge that is accessible, professional and youth-oriented, nurturing a new generation equipped with strong financial capabilities.

Event Details (Completed Event)

Event Name: YFPA Financial Education Forum – Money Monkey FinEd Forum
Date: Saturday, 28 March 2026
Venue: CyberArena, Cyberport (Cyberport Arcade, 100 Cyberport Road, Pok Fu Lam, Hong Kong)
Number of Participants: Over 170

BEIJING, April 2, 2026 /PRNewswire/ — LONGi has officially unveiled its LONGi ONE integrated solar-plus-storage strategy, marking a transition from traditional multi-vendor architectures to a unified system design.

A Shift from Fragmentation to Integration

As solar energy establishes itself as a core pillar of the global energy system, conventional “assembled” solutions are increasingly constrained by efficiency losses, complex commissioning, and unclear accountability. LONGi ONE addresses these challenges through full-stack, self-developed native integration, combining advanced BC solar technology with 5S storage technology to deliver a unified, high-performance “Solar Generator.”

One System, One Platform, One Responsibility

LONGi ONE is built upon three core principles: One System, One Platform, and One Responsibility.

Its natively integrated architecture reduces system losses, enhances performance, and shortens deployment timelines. The AI-driven platform enables coordinated optimization across generation, storage, and consumption.

Equally important, the One Responsibility principle redefines accountability in solar-storage systems. Instead of managing multiple vendors, customers work with a single partner—LONGi—across the entire lifecycle. This eliminates fragmented interfaces, avoids responsibility gaps, and ensures faster issue resolution with clear ownership.

A Comprehensive Product Portfolio

LONGi ONE delivers tailored solutions for two key market segments: utility-scale and commercial & industrial (C&I) applications.

For utility-scale projects, OneBank 2.0 offers a fully integrated AC/DC storage solution featuring advanced safety design. Its proprietary iCCS technology enables millisecond-scale fault detection and isolation, reducing system-level failure rates by 60% and cutting pre-commissioning time by over 30%.

OneMatrix 2.0 provides a flexible, modular approach for plant-level deployment, supporting multiple duration scenarios (2h/4h/8h) while reducing deployment time by 20-30% and lowering lifecycle costs.

For C&I users, Hi-MO One—paired with the EnergyOne platform—delivers 24.8% module efficiency and up to 90.3% system efficiency. With response times under 20 ms and AI-driven energy management, it enables intelligent operation and optimized returns.

Global Service Network Expansion

LONGi has also launched its “2830 Plan,” which aims to establish 30 localized service centers across key global markets by 2028.

Supported by 13 GWh of delivery experience across over 120 countries, this network will provide end-to-end lifecycle services, ensuring rapid, localized support worldwide.

Toward the Solar Generator Era

From monocrystalline to BC technology, and from PV to storage, LONGi remains committed to translating innovation into customer value. With LONGi ONE, the company aims to redefine solar energy as a stable and intelligent “Solar Generator”—supporting the next phase of the global energy transition.

DALLAS, April 2, 2026 /PRNewswire/ — Cango Inc. (NYSE: CANG), a leading Bitcoin miner leveraging its global operations to develop an integrated energy and AI compute platform, today announced two significant capital transactions: the closing of a US$65.0 million strategic investment from members of Company leadership, and the execution of a US$10.0 million convertible note financing agreement with DL Holdings Group Limited (HKEX: 1709) (“DL Holdings”), a Hong Kong-listed financial services group. The Company and DL Holdings have also entered into a memorandum of understanding (“MOU”) establishing a strategic cooperation framework.

Closing of US$65.0 Million Strategic Investment

Pursuant to the definitive investment agreements previously announced on February 12, 2026, the Company issued and sold an aggregate of 49,242,424 Class A ordinary shares to two entities, each wholly-owned by Mr. Xin Jin, Chairman of the Company’s board of directors, and Mr. Chang-Wei Chiu, a director of the Company, respectively. The transaction closed on March 31, 2026, generating net proceeds equivalent to US$65.0 million, settled in USDT, reinforcing the Company’s capital structure and reflecting leadership’s confidence in its strategic direction.

US$10 Million Convertible Note Financing and Strategic Partnership with DL Holdings

The Company entered into a securities purchase agreement with DL Holdings. Pursuant to the SPA, the Company issued and sold to DL Holdings a US$10,000,000 convertible note and a warrant to purchase up to 370,370 Class A ordinary shares at an exercise price of US$2.70 per share. Proceeds are intended for upstream acquisitions and expansion into AI and computing infrastructure.

The note matures on April 1, 2028, bears no interest (except upon default), and is convertible at US$1.62 per share beginning April 1, 2027. The warrant is exercisable immediately and expires on April 1, 2028.

In addition, the Company entered into an MOU with DL Holdings, outlining a proposed strategic cooperation framework. Under the MOU, DL Holdings has expressed its intention to make one or more strategic investments along with the Company, with an aggregate potential value of up to US$10 million. The contemplated investments are intended to support the Company’s initiatives in cryptocurrency mining facilities and AI.

These transactions are key steps in executing the Company’s previously disclosed financial strategy entering 2026: to strengthen its balance sheet, reduce leverage, and secure liquidity for its pivot toward AI infrastructure.

Contact: ir@cangoonline.com